Rock Creek Pharmaceuticals, Inc., a subsidiary of Star Scientific, Inc. (NASDAQ: CIGX), today announced that PGA Tour professional, Fred Couples, is the company’s first Brand Ambassador for Anatabloc™, its breakthrough product for anti-inflammatory support. Couples is a 32-year veteran of the PGA Tour, with over 50 professional tournament wins including the Masters (1992), and has been twice named the PGA Tour Player of the Year (1991, 1992). “I started taking Anatabloc™, and within a few days, I simply started feeling better,” said Couples. “There has been a difference in how I feel, both when I wake up in the morning and throughout my day. Anatabloc™ was an amazing find for me and I continue to feel better.” Introduced in August 2011, Anatabloc™ is a dietary supplement that assists the body’s natural process for regulating inflammation using an alkaloid found in plants and vegetables, combined with Vitamins A and D3 to assist in maintaining healthy levels of inflammation. Excessive inflammation is associated with a variety of autoimmune conditions, as well as athletic and work-out injuries. Anatabloc™ is now available through GNC.com. “We discovered from golf legend Fred Couples that he had been taking Anatabloc™ and we were delighted to hear he was feeling great and seeing real results,” said David Dean, Vice President, Sales and Marketing, Star Scientific. “Given his stature and popularity on and off the course, it made absolute sense to ask him to join our team as a Brand Ambassador. This year marks the 20 th anniversary of Couples’ win at the Masters and he will be playing in the Tournament. To be in the game at this level and playing this long is an amazing accomplishment.” Dean added. Couples will wear the Anatabloc™ logo on his sleeve at all tournaments going forward. Couples announced his partnership with Anatabloc™ and his use of the anti-inflammatory supplement at the Northern Trust Open—a tournament he almost won in 2011—at the Riviera Country Club in Pacific Palisades, CA.
Star Scientific (Nasdaq:CIGX) is trading at unusually high volume Friday with 3.9 million shares changing hands. It is currently at four times its average daily volume and trading down 21 cents (-7.1%).